JRA-H-Fullcolor.png

 

June 10, 2021
by Zachary Brousseau

RAPS announces board slate; Cooper, Salditt to serve second terms

The RAPS nominating committee has selected the slate of new members set to join the board for the term beginning 1 January 2022, following careful review of all nominations for two open director positions.

Following are the two incoming directors:

  • Carol Cooper, MS, RAC, IM(ASCP), RM(AAM), principal, CM Cooper and Associates
  • Diana Salditt, FRAPS, independent regulatory advisor, (formerly) senior program director, Medtronic 
Both Cooper and Salditt are current first-term board members in good standing who applied and were selected for a second term.

“These individuals have the knowledge, visibility, depth and breadth of experience, and commitment necessary to serve the organization well into the future. We are very encouraged by these regulatory professionals who are so enthusiastic and eager to serve in such an important leadership capacity,” said Nominating Committee Chair Don Boyer, BSc (Hons), RAC, FRAPS.

In accordance with RAPS bylaws, members may submit additional nominations through written petition, which must specify a qualified candidate’s name and position sought, and must bear the names, contact information and signatures of at least 50 active or life members in good standing. Petitions must be submitted electronically to the RAPS nominating committee via [email protected] by 12 July 2021. If no nomination petitions are received, the slate of incoming board members will be confirmed on 13 July 2021.
×

Welcome to the new RAPS Digital Experience

We have completed our migration to a new platform and are pleased to introduce the updated site.

What to expect: If you have an existing login, please RESET YOUR PASSWORD before signing in. After you log in for the first time, you will be prompted to confirm your profile preferences, which will be used to personalize content.

We encourage you to explore the new website and visit your updated My RAPS page. If you need assistance, please review our FAQ page.

We welcome your feedback. Please let us know how we can continue to improve your experience.